April 18, 2026 11:03 PM
Latest:
  • Teck Resources Q1 Earnings: Defying Copper Industry Weakness
  • Equinox Ups Its Offer For Calibre: Investors Said No!
  • First Quantum Q1 Earnings: Copper Major Still Bleeding Cash
  • Barrick’s $1 Billion Donlin Gold Sale: Why Everyone Agrees It’s a Win
  • Agnico Eagle Q1 Earnings: Costs Go Down?!
The Deep Dive

the deep dive

Providing stock analysis for investors of the Canadian junior markets

  • Home
  • Latest
    • Automotive
    • Cannabis
    • Commentary
    • Full Analysis
    • Gold
    • Industrials
    • Macro
    • Oil
    • Resources
    • Technology
  • Resources
  • Energy
  • Technology
  • Coverage Companies
    • Brazil Potash
    • Canadian Copper
    • Cardiol Therapeutics
    • Cytophage Technologies
    • ESGold Corp
    • First Majestic Silver
    • Golden Cariboo Resources
    • Nations Royalty Corp
    • Plurilock Security
    • Power Metallic
    • PTX Metals
    • Riverside Resources
    • Rua Gold
    • Silver47 Exploration
    • Sonoro Gold
    • Spirit Blockchain
    • Temas Resources
  • Verses AI
  • About
  • Contact Us

MindMed

Biotech Latest 

MindMed Activist Investor Moves To Take Control Of Board

April 21, 2023 9:41 AM Jay Lutz 0 Comments FCM MM Holdings, Mind Medicine, MindMed

MindMed (NASDAQ: MNMD) has seen its activist investor file a preliminary proxy statement for its proposed set of directors after

Share
Tweet
Share
Reddit
Read more
Biotech Latest 

Proxy Fight Looms For MindMed Vs. Co-Founder

April 19, 2023 9:43 AMApril 19, 2023 9:12 AM ER Velasco 0 Comments Mind Medicine, MindMed

Mind Medicine’s (NASDAQ: MNMD) filed its preliminary proxy materials on Tuesday with the U.S. Securities and Exchange Commission (SEC) for its

Share
Tweet
Share
Reddit
Read more
Biotech Latest 

MindMed Expects Results For Anxiety, ADHD Trials By Late 2023

January 9, 2023 10:40 AMJanuary 9, 2023 10:40 AM ER Velasco 0 Comments Mind Medicine, MindMed

It seems it is business as usual for Mind Medicine, aka MindMed, (NASDAQ: MNMD) as the firm gave updates on

Share
Tweet
Share
Reddit
Read more
Biotech Latest 

Activist Investor Calls For MindMed CEO’s Termination Due To Alleged Fraudulent Acts

November 3, 2022 3:10 PMNovember 3, 2022 1:59 PM ER Velasco 0 Comments Mind Medicine, MindMed

FCM MM Holdings, one of Mind Medicine’s (NEO: MMED) shareholders with a 6.1% stake, has formally filed a complaint with

Share
Tweet
Share
Reddit
Read more
Biotech Latest 

Mindmed: Canaccord Calls Financing “Puzzling And Unusual”

October 1, 2022 1:04 PMOctober 1, 2022 7:59 AM Justin Young 0 Comments Analyst Estimate, Mind Medicine, MindMed

This past week Mind Medicine Inc. (NEO: MMED) announced that they would be doing a public offering of 7,058,823 units

Share
Tweet
Share
Reddit
Read more
Latest Psychedelics 

Mind Medicine Prices $30 Million Offering At 30% Discount To Market

September 28, 2022 9:28 AMSeptember 28, 2022 9:28 AM Jay Lutz 0 Comments Mind Medicine, MindMed

Mind Medicine (NEO: MMED) has elected to destroy shareholder value in a major way this morning, pricing yet another financing

Share
Tweet
Share
Reddit
Read more
Biotech Latest 

MindMed Starts Dosing Patients In Phase 1 Clinical Study On MDMA-Like Substances

September 21, 2022 11:23 AMSeptember 21, 2022 10:33 AM ER Velasco 0 Comments Mind Medicine, MindMed

Mind Medicine Inc. (NEO: MMED), more commonly known as MindMed, announced on Tuesday that the first patient has been dosed

Share
Tweet
Share
Reddit
Read more
Biotech Latest 

MindMed Sees Positive Results For Its LSD Treatment For Anxiety Disorders Published In Peer-Reviewed Journal

September 8, 2022 5:03 PMSeptember 8, 2022 4:31 PM ER Velasco 0 Comments Mind Medicine, MindMed

Mind Medicine Inc. (NEO: MMED), more commonly known as MindMed, announced on Thursday that the previously released positive topline data

Share
Tweet
Share
Reddit
Read more
Latest Psychedelics 

Mindmed Completes 15-To-1 Reverse Split To Maintain Nasdaq Compliance

August 29, 2022 8:21 AMAugust 29, 2022 8:22 AM Jay Lutz 0 Comments Mind Medicine, MindMed

Mind Medicine (NEO: MMED) might be slightly more volatile over the next few sessions. The psychedelic firm late on Friday

Share
Tweet
Share
Reddit
Read more
Latest Psychedelics Retail 

20-Year-Old Makes $110 Million From Bed Bath & Beyond Stock.. Next Stop: MindMed

August 18, 2022 9:26 AMAugust 18, 2022 10:13 AM JP Alegre 0 Comments Bed Bath and Beyond, Jake Freeman, Meme Stocks, MindMed

20-year-old Jake Freeman just walked away with around $110 million from selling his 6.21% stake in meme-stock favorite Bed Bath

Share
Tweet
Share
Reddit
Read more
  • ← Previous

Latest

  • Teck Resources Q1 Earnings: Defying Copper Industry Weakness

  • Equinox Ups Its Offer For Calibre: Investors Said No!

  • First Quantum Q1 Earnings: Copper Major Still Bleeding Cash

  • Barrick’s $1 Billion Donlin Gold Sale: Why Everyone Agrees It’s a Win

  • Agnico Eagle Q1 Earnings: Costs Go Down?!

  • Why Gold Is Secretly Flooding Into The U.S. & Who’s Suppressing Silver?! | Andy Schectman

  • Gold @ $3500: All We Need Is $700 To Break Even! | Brad Kitchen – ESGOLD Corp.

  • Canada Is Nearly Last In Growth Among OECD Countries

Video

Teck Resources Q1 Earnings: Defying Copper Industry Weakness
Full Analysis Latest Resources Video Series 

Teck Resources Q1 Earnings: Defying Copper Industry Weakness

April 27, 2025 4:40 PM Jay Lutz 0

Yesterday in our coverage of First Quantum Mining’s business we said it was a terrible time to be a copper

Trending

  • Zentek Begins Four-Year Research Program With Ford Powertrain Engineering R&D Centre
  • Missouri Cannabis Sales Rake in $240 Million in New Tax Revenue Over Past Year
  • Trudeau’s Decision to Sell Canada’s Gold Reserves Has Now Cost Canada Over $149 million
  • Canada Is Nearly Last In Growth Among OECD Countries
  • The Golden Triangle: British Columbia’s Exploration Hotbed

News

Cardiol Sees First Patient Enrolled Under Phase III MAVERIC Clinical Trial
Biotech Latest News 

Cardiol Sees First Patient Enrolled Under Phase III MAVERIC Clinical Trial

April 17, 2025 7:59 AM Jay Lutz 0

Cardiol Therapeutics (TSX: CRDL) has reached a major milestone with the announcement that the first patients have been enrolled into a phase III clinical trial for its lead drug candidate, CardiolRx™.

Rua Gold Hits 13.3 g/t Gold, 8.1% Antimony Over 1.25 Metres At Auld Creek
Latest News Resources 

Rua Gold Hits 13.3 g/t Gold, 8.1% Antimony Over 1.25 Metres At Auld Creek

April 16, 2025 8:29 AM Jay Lutz 0
Canadian Copper To Begin Exploration At Murray Brook East
Latest News Resources 

Canadian Copper To Begin Exploration At Murray Brook East

April 15, 2025 10:30 AM Jay Lutz 0

About

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations listed on the CSE and the TSX Venture to create quality stock analysis for investors.

Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Menu

  • Home
  • About
  • Research
  • Discover
  • Contact Us
  • Disclaimer

Categories

  • Automotive
  • Biotech
  • Bonds
  • Cannabis
  • Commentary
  • Crypto
  • Education
  • Energy
  • Entertainment
  • Esports
  • ETFs
  • Food
  • Full Analysis
  • Healthcare
  • Industrials
  • Latest
  • Lithium
  • Macro
  • Market Movers
  • Mental Hurdles
  • News
  • Oil
  • Politics
  • Psychedelics
  • Real Estate
  • Resources
  • Retail
  • SPACs
  • Technology
  • Video Series
Copyright © 2026 the deep dive. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.